2018
DOI: 10.1590/s1808-185120181704191006
|View full text |Cite
|
Sign up to set email alerts
|

Apoptosis, Nutrition, and Metabolism of Transplanted Intervertebral Disc Cells

Abstract: Introduction: Apoptosis is a contributing factor to degenerating intervertebral disc (IVD). Disc regeneration has been attempted by transplanting cells into the disc, with some gains in disc height achieved in animal models. Here, we study whether the apoptotic microenvironment affects the transplanted disc cells. Methods: Human annulus fibrosus (AF) and nucleus pulposus (NP) cells were grown in media then starved for 5 days in vitro by not changing the media. Three aspects of apoptotic cell influence on the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 16 publications
(15 reference statements)
0
2
0
Order By: Relevance
“…14 , 15 , 16 As a result of the changes in IVD biology, diffusion rates decrease dramatically, leading to poor nutrition (ie, glucose and oxygen), high acidity, and high cell death. 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…14 , 15 , 16 As a result of the changes in IVD biology, diffusion rates decrease dramatically, leading to poor nutrition (ie, glucose and oxygen), high acidity, and high cell death. 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 …”
Section: Introductionmentioning
confidence: 99%
“…[14][15][16] As a result of the changes in IVD biology, diffusion rates decrease dramatically, leading to poor nutrition (ie, glucose and oxygen), high acidity, and high cell death. [17][18][19][20][21][22][23][24][25][26][27][28][29][30] In addition, clinical stem cell studies reported widely varying cell doses being administered to treat IVD degeneration, ranging from 1 million to 40 million cells per patient as reviewed by Sakai and Schol. 4,21,22,[31][32][33][34][35][36][37][38] Considering the lack of nutrient supply in the human IVD, 13 we believed it was essential to model the patient-specific nutrient distributions before cell therapy and identify the appropriate dose of cell injections based on the nutritional capacity of the individual disc.…”
mentioning
confidence: 99%